Skip to main content

Table 1 Demographics and clinical data of the studied patients

From: The 3′-UTR of the adiponectin Q gene harbours susceptibility loci for atherosclerosis and its metabolic risk traits

  Controls Cases
  All Male Female All Male Female
CAD 2307 1257(54.5) 1050(45.5) 2339 1789(76.5) 550(23.5)
MI 1640 826(50.4) 814(49.6) 3005 2220(73.9) 785(26.1)
FH 3735 2451(65.6) 1284(34.4) 911 595(65.3) 316(34.7)
T2DM 2086 1335(64.0) 751(36.0) 2559 1710(66.8) 849(33.2)
HTN 1101 729(66.2) 372(33.8) 3541 2313(65.3) 1228(34.7)
OBS 2472 1784(72.2) 688(27.8) 1589 880(55.4) 709(44.6)
lHDLC 2156 1244(57.7) 912(42.3) 1762 1353(76.8) 409(23.2)
hChol 2019 1306(64.7) 713(35.3) 2441 1615(66.2) 826(33.8)
hTG 2842 1834(64.5) 1008(35.5) 1094 778(71.1) 316(28.9)
Smokers 2768 1310(47.3) 1458(52.7) 1759 1684(95.7) 75(4.3)
Clinical characteristics (relative to coronary artery disease)
Age 50.4 ± 0.4 51.2 ± 0.5 49.8 ± 0.5 60.3 ±0.2 59.8 ± 0.3 61.8 ± 0.54
BMI 29.0 ±0.2 27.97 ± 0.2 30.3 ± 0.3 28.9 ± 0.1 28.3 ± 0.1 31.0 ± 0.3
Total Chol 4.51 ± 0.02 4.42 ± 0.03 4.62 ± 0.03 4.48 ± 0.02 4.43 ±0.03 4.66 ± 0.05
HDL-Chol 1.26 ±0.01 1.18 ±0.03 1.33 ±0.01 1.15 ±0.01 1.15 ± 0.01 1.25 ± 0.02
LDL-Chol 2.76 ± 0.02 2.73 ± 0.03 2.80 ±0.03 2.71 ±0.02 2.68 ± 0.02 2.84 ±0.06
TG 1.52 ± 0.02 1.60 ± 0.03 1.44 ± 0.03 1.78 ± 0.02 1.78 ± 0.03 1.78 ± 0.05
FG 6.87 ± 0.16 6.80 ± 0.23 6.92 ± 0.22 9.45 ± 0.31 9.27 ± 0.37 9.88 ± 0.56
BP 120/83 119/81 121/82 128/84 130/85 127/83
  1. The numbers in brackets give the fraction of the total (all) values of the group. BMI, body mass index; BP, blood pressure; CAD, coronary artery disease; Chol, cholesterol; FG, fasting glucose; FH, family history of CAD; MI, myocardial infarction; TG, triglycerides; T2DM, type 2 diabetes mellitus; hLDLC, high low density lipoprotein-cholesterol; hChol, hypercholesterolaemia; HDL, high density lipoprotein; hTG, hypertriglyceridaemia; HTN, hypertension; LDL, low density lipoprotein; lHDLC, low high density lipoprotein-cholesterol; OBS, obesity.